View in EDS PDF Full Text

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.

Saved in:
Bibliographic Details
Title: Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.
Authors: Bigos, K. L., Bies, R. R., Pollock, B. G., Lowy, J. J., Zhang, F., Weinberger, D. R.
Source: Molecular Psychiatry. Jun2011, Vol. 16 Issue 6, p620-625. 6p. 3 Charts, 2 Graphs.
Subjects: Olanzapine, Human genetic variation, Cytochrome P-450, Racial differences, Clinical medicine, Side effects of antipsychotic drugs, Genetic polymorphisms
Abstract: The antipsychotic drug, olanzapine, one of the most widely used drugs in clinical medicine, has a high rate of discontinuation due to inefficacy and/or adverse effects. We identified a single nucleotide polymorphism in the drug metabolizing enzyme, cytochrome P450 3A43 (CYP3A43; rs472660), that highly significantly predicted olanzapine clearance in the Clinical Antipsychotic Trials of Intervention Effectiveness trial (P=5.9e−7). Moreover, at standard antipsychotic doses, 50% of individuals with the high clearance genotype (AA) have trough blood levels below the therapeutic range. Interestingly, a much higher proportion of African Americans carry the A allele compared with Caucasians (allele frequency 67 vs 14%). After accounting for CYP3A43 genotype, race is no longer a significant predictor of olanzapine clearance. Olanzapine clearance was associated with measures of clinical response. Patients with greater clearance had higher symptom ratings and were more likely to discontinue treatment due to an inadequate response. Our data identify a genetic mechanism for variation in olanzapine response and demonstrate that blood level monitoring of olanzapine treatment is advisable. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 60780208
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bigos%2C+K%2E+L%2E%22">Bigos, K. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Bies%2C+R%2E+R%2E%22">Bies, R. R.</searchLink><br /><searchLink fieldCode="AR" term="%22Pollock%2C+B%2E+G%2E%22">Pollock, B. G.</searchLink><br /><searchLink fieldCode="AR" term="%22Lowy%2C+J%2E+J%2E%22">Lowy, J. J.</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang%2C+F%2E%22">Zhang, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Weinberger%2C+D%2E+R%2E%22">Weinberger, D. R.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Psychiatry%22">Molecular Psychiatry</searchLink>. Jun2011, Vol. 16 Issue 6, p620-625. 6p. 3 Charts, 2 Graphs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Olanzapine%22">Olanzapine</searchLink><br /><searchLink fieldCode="DE" term="%22Human+genetic+variation%22">Human genetic variation</searchLink><br /><searchLink fieldCode="DE" term="%22Cytochrome+P-450%22">Cytochrome P-450</searchLink><br /><searchLink fieldCode="DE" term="%22Racial+differences%22">Racial differences</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+medicine%22">Clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Side+effects+of+antipsychotic+drugs%22">Side effects of antipsychotic drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Genetic+polymorphisms%22">Genetic polymorphisms</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The antipsychotic drug, olanzapine, one of the most widely used drugs in clinical medicine, has a high rate of discontinuation due to inefficacy and/or adverse effects. We identified a single nucleotide polymorphism in the drug metabolizing enzyme, cytochrome P450 3A43 (CYP3A43; rs472660), that highly significantly predicted olanzapine clearance in the Clinical Antipsychotic Trials of Intervention Effectiveness trial (P=5.9e−7). Moreover, at standard antipsychotic doses, 50% of individuals with the high clearance genotype (AA) have trough blood levels below the therapeutic range. Interestingly, a much higher proportion of African Americans carry the A allele compared with Caucasians (allele frequency 67 vs 14%). After accounting for CYP3A43 genotype, race is no longer a significant predictor of olanzapine clearance. Olanzapine clearance was associated with measures of clinical response. Patients with greater clearance had higher symptom ratings and were more likely to discontinue treatment due to an inadequate response. Our data identify a genetic mechanism for variation in olanzapine response and demonstrate that blood level monitoring of olanzapine treatment is advisable. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=60780208
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/mp.2011.38
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 620
    Subjects:
      – SubjectFull: Olanzapine
        Type: general
      – SubjectFull: Human genetic variation
        Type: general
      – SubjectFull: Cytochrome P-450
        Type: general
      – SubjectFull: Racial differences
        Type: general
      – SubjectFull: Clinical medicine
        Type: general
      – SubjectFull: Side effects of antipsychotic drugs
        Type: general
      – SubjectFull: Genetic polymorphisms
        Type: general
    Titles:
      – TitleFull: Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bigos, K. L.
      – PersonEntity:
          Name:
            NameFull: Bies, R. R.
      – PersonEntity:
          Name:
            NameFull: Pollock, B. G.
      – PersonEntity:
          Name:
            NameFull: Lowy, J. J.
      – PersonEntity:
          Name:
            NameFull: Zhang, F.
      – PersonEntity:
          Name:
            NameFull: Weinberger, D. R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2011
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-print
              Value: 13594184
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Molecular Psychiatry
              Type: main
ResultId 1